June 25th, 2021 | 14:01 CEST
BYD, Siemens Healthineers, Silver Viper: Many trends in one share
Table of contents:
"[...] Internally we expect the resource to significantly grow the deeper we mine. [...]" Dennis Karp, Executive Chairman, Manuka Resources
BYD: These brands are interesting now
Electric car pioneer BYD is considered the darling of investors. There are several reasons for this: The Chinese have their production of batteries and a chip division. The latter products are in short supply worldwide. Some carmakers have even had to temporarily shut down their production lines because of a lack of supplies. BYD is not experiencing this. The Company recently announced that it would raise the prices of its chips from its production by 5% - demand is high and supply is scarce. While other automakers are suffering, BYD is making money.
BYD is also strong in terms of quality and range. In the spring, the Chinese presented a platform that should also enable other manufacturers to realize ranges of over 1,000 km with the help of blade batteries from BYD. German manufacturers usually stop much earlier. The technological progress coupled with the good strategic position speaks for the BYD share. Currently, however, the recovery movement has stalled somewhat. Important marks on the upside are EUR 25 and EUR 28.25 in German trading. If these areas are overcome on a closing price basis and confirmed on the domestic stock exchange, the journey can continue.
Siemens Healthineers: Health as a permanent theme
A trend that has been intact for years and has been given new impetus by the pandemic is the development of increasingly complex medical technology. Hardly any ailment is diagnosed these days without imaging procedures. The extent to which this makes sense is anyone's guess, but the trend among doctors and patients alike is toward wanting to see problems "in black and white." Here is where Siemens Healthineers comes in. Imaging plays an important role for the Company and accounts for more than 60% of its sales. The other divisions are diagnostic devices and therapy forms.
In the meantime, modern medical technology devices are also playing a role in more and more medical practices and are not only found in radiologists' offices. Siemens Healthineers has also done good business with corona tests in recent months. Although many regular examinations were postponed during the pandemic, they have recently been made up. The Company operates in an exciting area and at least offers a slim dividend. The stock has just broken out to a new high. That is usually a buy signal. However, it makes sense to target the stock only if it falls below the EUR 50 mark - after all, the profit is in the purchase.
Silver Viper: Investors show confidence
Investors can also hope for good entry opportunities at Silver Viper. The Company is developing silver projects in Mexico. Silver plays a role in electromobility and medical technology, and there is even silver in solar cells. Therefore, those who cannot decide between the trends mentioned above could therefore consider an investment in a silver company and thus kill several birds with one stone. After all, silver is also a precious metal and interesting in crisis prevention and inflation. Silver Viper primarily operates the La-Virginia project and has recently completed 100 drill holes with a distance of 27,021m. Most recently, the results were incorporated into a resource estimate according to common mining standards. The project thus becomes more quickly understandable even for investors who do not follow the Company closely - this can ensure increased interest on the part of investors.
Also recently, the Company announced a capital measure: CAD 6 million is to flow into the Company. Market participants, including existing shareholders, could purchase the new shares at CAD 0.47. Via warrants, which can be exercised at CAD 0.65, the Company could receive another CAD 8.3 million over the next two years. Thus, the financing seems to be secured. As the share has shown a good development in the past months, the level for the capital increase seems fair. As Silver Viper is valued, as a project developer, at a discount to the resources in the ground, the stock can offer leverage to the silver price. The paper is a possible addition for speculatively oriented investors. Many trends, such as electromobility, solar energy and medical technology, resonate indirectly with Silver Viper.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.
Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.